Fig. 3: The risk-based surveillance arrangements varied 27 to 5 visits for early detection of disease failure.

The follow-up arrangements for a total of 13 visits for group III are highlighted in the orange box.

The follow-up arrangements for a total of 13 visits for group III are highlighted in the orange box.